Which hedge funds own MIRM? MIRUM PHARMACEUTICALS INC, Q2 2026 13F holders
54 tracked hedge funds disclosed a position in MIRM (MIRUM PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $2.0bn in total. The largest holder by portfolio weight is Frazier Life Sciences Management, L.P. at 19.6% of its book. 11 opened a new position this quarter: Seven Fleet Capital Management LP, Resolute Capital Asset Partners LLC, Warberg Asset Management LLC, Capricorn Fund Managers Ltd. 16 exited: Paradigm Biocapital Advisors LP, Logos Global Management LP, Cinctive Capital Management LP.
- 54
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 11
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 16
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $63.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $272m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.0bn
- Combined value Sum of the holders' reported positions in the security.
- 4.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Paradigm Biocapital Advisors LP | 1.2% | $57.7m |
| Logos Global Management LP | 1.0% | $18.5m |
| Cinctive Capital Management LP | 0.2% | $3.6m |
| Point72 Asset Management, L.P. | 0.1% | $60.2m |
| CenterBook Partners LP | 0.10% | $1.8m |
| ExodusPoint Capital Management, LP | 0.08% | $8.1m |
| Citadel Advisors LLC | 0.07% | $97.2m |
| Voloridge Investment Management, LLC | 0.04% | $9.6m |
| Linden Advisors LP | 0.03% | $6.0m |
| Capital Fund Management S.A. | 0.02% | $1.8m |
| RWC Asset Management LLP | 0.01% | $216k |
| Hudson Bay Capital Management LP | 0.0% | $788k |
| Arrowstreet Capital, Limited Partnership | 0.0% | $6.3m |
| Farallon Capital Management, L.L.C. | 0.0% | $277k |
| Marshall Wace, LLP | 0.0% | $430k |
| Elequin Capital, LP | 0.0% | $3.7k |
Ownership over time
Who discovered MIRM first? Beta
| Deerfield Management Company, L.P. | Q3 2019 | +4.7 pts |
| Prosight Management, LP high conviction | Q3 2022 | +4.5 pts |
| Soleus Capital Management, L.P. | Q1 2022 | +1.3 pts |
| Cadian Capital Management, LP | Q2 2022 | +1.1 pts |
| MPM Bioimpact LLC | Q2 2024 | +0.6 pts |
| Sio Capital Management, LLC | Q4 2020 | +0.5 pts |
| Lion Point Capital, LP | Q3 2022 | +0.4 pts |
| First Light Asset Management, LLC | Q2 2022 | 0.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.